Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative
2 other identifiers
interventional
4,809
1 country
1
Brief Summary
The goal of this study is to evaluate the effectiveness of a multi-level health-related social needs (HRSN) initiative among adult patients diagnosed with type 2 diabetes, plus hypertension or hyperlipidemia. The multi-level initiative includes HRSN data collection, training and tools for health care professionals, care coordinator support, and community resources. Patients with type 2 diabetes plus hypertension or hyperlipidemia will be screened for HRSN as part of the primary care clinic intake process to assess if patients have any social needs (like difficulty with getting food, housing, or transportation). If patients screen positive for having social needs, then patients will be offered support, which can include help from primary care providers with adjusting a patient's disease management plan, referrals to care coordinators to provide additional assistance in addressing social needs, and information about community organizations that offer resources for social needs. The initiative will be integrated as a system change across VUMC adult primary care practices. The investigators will use a prospective, single-arm clinical trial to evaluate effects on clinical outcomes for 12 months. Data will be extracted from the EHR on adult patients diagnosed with type 2 diabetes, and either hypertension or hyperlipidemia. The investigators hypothesize that the initiative will reduce the impact of HRSN on clinical outcomes over the study period. The investigators will also administer surveys to a subgroup of patients to examine trends in self-reported psychosocial and behavioral measures over the course of the initiative.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 24, 2025
CompletedFirst Submitted
Initial submission to the registry
February 13, 2025
CompletedFirst Posted
Study publicly available on registry
February 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 4, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 4, 2026
March 11, 2026
March 1, 2026
1.6 years
February 13, 2025
March 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in glycemic control
Hemoglobin A1c extracted from the electronic health record where higher values indicate worse glycemic control.
Baseline and 12 months post-baseline
Secondary Outcomes (2)
Change in cholesterol
Baseline and 12 months post-baseline
Change in blood pressure
Baseline and 12 months post-baseline
Other Outcomes (8)
Change in medication adherence (survey)
Baseline and 6 months post-baseline
Change in dietary behavior (survey)
Baseline and 6 months post-baseline
Change in dietary behavior (survey)
Baseline and 6 months post-baseline
- +5 more other outcomes
Study Arms (1)
Multi-level HRSN initiative
EXPERIMENTALEligible patients will receive the HRSN initiative as part of their primary care appointments
Interventions
The multi-level health-related social needs (HRSN) initiative includes multiple components aimed at assessing and addressing HRSN in clinical practice: HRSN screening, EHR tools for clinical decision support, training and tools for health care providers to address HRSN, care coordinator support for patient outreach, and community resources for referral and support.
Eligibility Criteria
You may qualify if:
- years of age or older
- Completed the health-related social needs (HRSN) screener as part of a primary care visit
- Diagnosed with type 2 diabetes, plus hypertension and/or hyperlipidemia as reflected by ICD-10 billing codes
- Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
- ELIGIBILITY CRITERIA FOR PATIENT SURVEYS (subset of EHR data)
- years of age or older
- Completed the HRSN screener as part of a primary care visit
- Diagnosed with type 2 diabetes
- Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
- English-speaking
You may not qualify if:
- Blindness
- Hearing impairment
- Conditions that would interfere with survey completion (e.g., significant dementia, active psychosis or mania)
- Being near the end of life (hospice or home hospice)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sunil Kripalani, MD, MSc
Vanderbilt University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 13, 2025
First Posted
February 17, 2025
Study Start
January 24, 2025
Primary Completion (Estimated)
September 4, 2026
Study Completion (Estimated)
September 4, 2026
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After study results are posted on clinical trials and outcomes published in a peer-reviewed journal, until 5 years later
- Access Criteria
- Contact the principal investigator
After study results are posted on clinical trials and published, de-identified data will be available upon requests made to the principal investigator.